Derek M Novacek, Kenneth L Subotnik, Joseph Ventura, Laurie R Casaus, Fiona Whelan, Catherine A Sugar, Keith H Nuechterlein
{"title":"“黑人、拉丁裔和白人首发精神病患者口服与长效注射利培酮的阳性症状和药物依从性”的更正[精神分裂症,(2025)160-166]。","authors":"Derek M Novacek, Kenneth L Subotnik, Joseph Ventura, Laurie R Casaus, Fiona Whelan, Catherine A Sugar, Keith H Nuechterlein","doi":"10.1016/j.schres.2025.09.026","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to \\\"Positive symptoms and medication adherence in response to oral versus long-acting injectable risperidone in black, latino, and white first-episode psychosis patients\\\" [Schizophr Res. (2025) 160-166].\",\"authors\":\"Derek M Novacek, Kenneth L Subotnik, Joseph Ventura, Laurie R Casaus, Fiona Whelan, Catherine A Sugar, Keith H Nuechterlein\",\"doi\":\"10.1016/j.schres.2025.09.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":21417,\"journal\":{\"name\":\"Schizophrenia Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Schizophrenia Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.schres.2025.09.026\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.schres.2025.09.026","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Corrigendum to "Positive symptoms and medication adherence in response to oral versus long-acting injectable risperidone in black, latino, and white first-episode psychosis patients" [Schizophr Res. (2025) 160-166].
期刊介绍:
As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!
Schizophrenia Research''s time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.
The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.